Abstract
Levodopa/Carbidopa 5.0/1.25 mg/mL in SyrSpend SF pH4
Author(s): Allen Loyd V Jr
Issue: Mar/Apr 2021 - Volume 25, Number 2
Page(s): 145
Download in electronic PDF format for $75
Abstract
A formulation for preparing Levodopa/Carbidopa 5.0/1.25 mg/mL in SyrSpend SF pH4. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.
Related Keywords
- formulation
- levodopa
- carbidopa
- parkinsonian syndrome
- parkinsonism
- decarboxylase inhibitor
- stability
Related Categories
- EXCIPIENTS
- FORMULATIONS
- DOSAGE FORMS/DRUG CARRIERS
- MUSCULOSKELETAL DISORDERS
- NEUROLOGY